Showing results (391-400 of 512) with videos related to

Sort By:
Pageof 52
Multiple Sclerosis and Related Disorders|June 14, 2022
Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapiesLars Masanneck, Leoni Rolfes, Liesa Regner-Nelke, et al.
Journal of Neuroimmunology|November 26, 2008
Neuroprotection and enhanced neurogenesis by extract from the tropical plant Knema laurina after inflammatory damage in living brain tissueInes Häke, Silvia Schönenberger, Jens Neumann, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 30, 2026
Treatment approaches to patients with multiple sclerosis and coexisting psoriasis - A longitudinal multicenter observational cohort studyTobias Brummer, Saskia Räuber, Jasmin Jakob, et al.
Brain, Behavior, and Immunity|November 2, 2022
Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: Analysis of 49 autoantibodies in over 7000 subjectsVinicius Daguano Gastaldi, Justus Bh Wilke, Cosima A Weidinger, et al.
Ebiomedicine|September 27, 2021
NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort studyTimo Uphaus, Falk Steffen, Muthuraman Muthuraman, et al.
Annals of Neurology|October 3, 2009
Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitisJohannes Vogt, Friedemann Paul, Orhan Aktas, et al.
Plos One|April 25, 2013
Parallelized TCSPC for dynamic intravital fluorescence lifetime imaging: quantifying neuronal dysfunction in neuroinflammationJan Leo Rinnenthal, Christian Börnchen, Helena Radbruch, et al.
Neuroimage|January 18, 2015
A human post-mortem brain model for the standardization of multi-centre MRI studiesAmgad Droby, Carsten Lukas, Anne Schänzer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 4, 2015
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosisFelix Luessi, Stefan Kraus, Bettina Trinschek, et al.
Therapeutic Advances in Neurological Disorders|March 22, 2012
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in GermanyAnke Stroet, Claudia Hemmelmann, Michaela Starck, et al.
Pageof 52